Drug Eluting Stent Market Size, Share, Trends, Growth Outlook

Drug Eluting Stent Market is estimated to increase at a growth rate of 8.9% CAGR over the forecast period from 2024 to 2030.

The Drug Eluting Stent Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Coating (Polymer-based Coatings, Polymer free Coatings), By Application (Coronary Artery Disease, Peripheral Artery Disease).

 

An Introduction to Drug Eluting Stent Market in 2024

The drug-eluting stent (DES) market in 2024 serves the demand for interventional cardiology devices used in the treatment of coronary artery disease (CAD) and peripheral artery disease (PAD) through percutaneous coronary intervention (PCI) and peripheral vascular intervention (PVI) procedures. Drug-eluting stents are implantable medical devices made of metal scaffolds coated with antiproliferative drugs and polymers that inhibit neointimal hyperplasia and reduce the risk of restenosis and stent thrombosis following arterial angioplasty and stent placement. They provide sustained drug release and local drug delivery to the vessel wall, promoting vascular healing and preventing re-narrowing of the arteries. Market dynamics are driven by factors such as the increasing prevalence of cardiovascular diseases, the growing demand for minimally invasive treatment options, and advancements in stent design, drug formulations, and biocompatible coatings for improved safety and efficacy. Collaboration between medical device manufacturers, interventional cardiologists, and regulatory agencies drives innovation and market growth in drug-eluting stents, supporting better clinical outcomes and quality of life for patients with coronary and peripheral artery disease.

 

Drug Eluting Stent Market Trend: Shift Towards Biodegradable Drug Eluting Stents

A significant trend in the Drug Eluting Stent market is the shift towards biodegradable drug eluting stents. Traditional drug eluting stents (DES) utilize polymers to release drugs that prevent restenosis and promote healing after angioplasty. However, concerns over long-term complications related to polymer persistence have led to the development of biodegradable stent coatings that gradually degrade over time, reducing the risk of inflammation and thrombosis. This trend is driven by the desire to improve long-term outcomes and patient safety, as well as regulatory efforts to address concerns over polymer-associated adverse events. Additionally, biodegradable DES offer the potential for complete vessel healing and restoration of vascular function, further enhancing their appeal for patients and healthcare providers. As manufacturers invest in research and development to innovate biodegradable stent technologies, the market for Drug Eluting Stents is expected to witness a shift towards these next-generation devices, driving market growth and reshaping the landscape of interventional cardiology.

Drug Eluting Stent Market Driver: Increasing Incidence of Cardiovascular Diseases

A key driver in the Drug Eluting Stent market is the increasing incidence of cardiovascular diseases. Cardiovascular diseases, including coronary artery disease, remain a leading cause of morbidity and mortality worldwide, placing a significant burden on healthcare systems and society as a whole. Drug eluting stents play a crucial role in the management of coronary artery disease by restoring blood flow to the heart and reducing the risk of adverse cardiac events such as heart attacks and strokes. This driver is fueled by factors such as aging populations, sedentary lifestyles, unhealthy dietary habits, and the rising prevalence of risk factors such as obesity, diabetes, and hypertension. As the global burden of cardiovascular diseases continues to grow, the demand for interventional cardiology procedures, including percutaneous coronary intervention (PCI) with drug eluting stents, is expected to increase, driving market expansion in the Drug Eluting Stent segment.

Drug Eluting Stent Market Opportunity: Development of Next-Generation Drug-Eluting Stent Technologies

An opportunity for growth in the Drug Eluting Stent market lies in the development of next-generation drug-eluting stent technologies with improved efficacy, safety, and patient outcomes. While traditional DES have significantly reduced rates of restenosis compared to bare-metal stents, challenges remain in addressing issues such as late stent thrombosis, stent fracture, and long-term polymer-related complications. By investing in research and development, manufacturers can innovate new stent designs, drug formulations, and delivery systems that enhance drug elution kinetics, promote endothelialization, and minimize inflammation and thrombosis. Additionally, there is potential for synergistic approaches, such as combining drug eluting stents with bioresorbable scaffolds, drug-coated balloons, or local drug delivery technologies, to further improve clinical outcomes and reduce the need for long-term dual antiplatelet therapy. By embracing opportunities for innovation and collaboration, manufacturers can differentiate their products in the competitive landscape of interventional cardiology and address unmet needs in the treatment of coronary artery disease, driving market growth and improving patient care in the Drug Eluting Stent segment.

 

Drug Eluting Stent Market Segmentation

By Coating

Polymer-based Coatings

-Non-biodegradable Polymers

-Biodegradable Polymers

Polymer free Coatings

-Micro porous Surface

-Micro structured Surface

-Slotted Tubular Surface

-Nanoporous Surface

By Application

Coronary Artery Disease

Peripheral Artery Disease

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

 

Drug Eluting Stent Market Companies

Abbott Laboratories

AlviMedica Medical Technologies Inc

Biosensor International

Biosensors International Group Ltd

Biotronik SE & Co. KG

Boston Scientific Corp

Cook Medical

HangZhou HuaAn Biotechnology Co. Ltd

Medtronic Plc

MicroPort Scientific Corp

Stentys SA

Terumo Corp

 

Reasons to Buy the Drug Eluting Stent Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Drug Eluting Stent Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Drug Eluting Stent Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Drug Eluting Stent Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Drug Eluting Stent Market Size Outlook, $ Million, 2021 to 2030

3.2 Drug Eluting Stent Market Outlook By Type, $ Million, 2021 to 2030

3.3 Drug Eluting Stent Market Outlook By Product, $ Million, 2021 to 2030

3.4 Drug Eluting Stent Market Outlook By Application, $ Million, 2021 to 2030

3.5 Drug Eluting Stent Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Drug Eluting Stent Market Industry

4.2 Key Market Trends in Drug Eluting Stent Market Industry

4.3 Potential Opportunities in Drug Eluting Stent Market Industry

4.4 Key Challenges in Drug Eluting Stent Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Drug Eluting Stent Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Drug Eluting Stent Market Outlook By Segments

7.1 Drug Eluting Stent Market Outlook by Segments

By Coating

Polymer-based Coatings

-Non-biodegradable Polymers

-Biodegradable Polymers

Polymer free Coatings

-Micro porous Surface

-Micro structured Surface

-Slotted Tubular Surface

-Nanoporous Surface

By Application

Coronary Artery Disease

Peripheral Artery Disease

 

8 North America Drug Eluting Stent Market Analysis And Outlook To 2030

8.1 Introduction to North America Drug Eluting Stent Markets in 2024

8.2 North America Drug Eluting Stent Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Drug Eluting Stent Market size Outlook by Segments, 2021-2030

By Coating

Polymer-based Coatings

-Non-biodegradable Polymers

-Biodegradable Polymers

Polymer free Coatings

-Micro porous Surface

-Micro structured Surface

-Slotted Tubular Surface

-Nanoporous Surface

By Application

Coronary Artery Disease

Peripheral Artery Disease

 

9 Europe Drug Eluting Stent Market Analysis And Outlook To 2030

9.1 Introduction to Europe Drug Eluting Stent Markets in 2024

9.2 Europe Drug Eluting Stent Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Drug Eluting Stent Market Size Outlook By Segments, 2021-2030

By Coating

Polymer-based Coatings

-Non-biodegradable Polymers

-Biodegradable Polymers

Polymer free Coatings

-Micro porous Surface

-Micro structured Surface

-Slotted Tubular Surface

-Nanoporous Surface

By Application

Coronary Artery Disease

Peripheral Artery Disease

 

10 Asia Pacific Drug Eluting Stent Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Drug Eluting Stent Markets in 2024

10.2 Asia Pacific Drug Eluting Stent Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Drug Eluting Stent Market size Outlook by Segments, 2021-2030

By Coating

Polymer-based Coatings

-Non-biodegradable Polymers

-Biodegradable Polymers

Polymer free Coatings

-Micro porous Surface

-Micro structured Surface

-Slotted Tubular Surface

-Nanoporous Surface

By Application

Coronary Artery Disease

Peripheral Artery Disease

 

11 South America Drug Eluting Stent Market Analysis And Outlook To 2030

11.1 Introduction to South America Drug Eluting Stent Markets in 2024

11.2 South America Drug Eluting Stent Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Drug Eluting Stent Market size Outlook by Segments, 2021-2030

By Coating

Polymer-based Coatings

-Non-biodegradable Polymers

-Biodegradable Polymers

Polymer free Coatings

-Micro porous Surface

-Micro structured Surface

-Slotted Tubular Surface

-Nanoporous Surface

By Application

Coronary Artery Disease

Peripheral Artery Disease

 

12 Middle East And Africa Drug Eluting Stent Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Drug Eluting Stent Markets in 2024

12.2 Middle East and Africa Drug Eluting Stent Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Drug Eluting Stent Market size Outlook by Segments, 2021-2030

By Coating

Polymer-based Coatings

-Non-biodegradable Polymers

-Biodegradable Polymers

Polymer free Coatings

-Micro porous Surface

-Micro structured Surface

-Slotted Tubular Surface

-Nanoporous Surface

By Application

Coronary Artery Disease

Peripheral Artery Disease

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Abbott Laboratories

AlviMedica Medical Technologies Inc

Biosensor International

Biosensors International Group Ltd

Biotronik SE & Co. KG

Boston Scientific Corp

Cook Medical

HangZhou HuaAn Biotechnology Co. Ltd

Medtronic Plc

MicroPort Scientific Corp

Stentys SA

Terumo Corp

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Drug Eluting Stent Market Segmentation

By Coating

Polymer-based Coatings

-Non-biodegradable Polymers

-Biodegradable Polymers

Polymer free Coatings

-Micro porous Surface

-Micro structured Surface

-Slotted Tubular Surface

-Nanoporous Surface

By Application

Coronary Artery Disease

Peripheral Artery Disease

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)